Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile
Nathalie Wurtz, Gwilherm Penant, Priscilla Jardot, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2021) Vol. 40, Iss. 3, pp. 477-484
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors
Andrea Citarella, Angela Scala, Anna Piperno, et al.
Biomolecules (2021) Vol. 11, Iss. 4, pp. 607-607
Open Access | Times Cited: 132
Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models
Lena Mautner, Mona Hoyos, Alexandra Dangel, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 96
SARS-CoV-2 Infection of Microglia Elicits Proinflammatory Activation and Apoptotic Cell Death
Gi Uk Jeong, Jaemyun Lyu, Kyun-Do Kim, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 93
The puzzling mutational landscape of the SARS‐2‐variant Omicron
Jacques Fantini, Nouara Yahi, Philippe Colson, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2019-2025
Open Access | Times Cited: 77
Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis
Konstantinos Evangelou, Dimitris Veroutis, Koralia Paschalaki, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 2, pp. 2102951-2102951
Open Access | Times Cited: 70
Culture and identification of a “Deltamicron” SARS‐CoV‐2 in a three cases cluster in southern France
Philippe Colson, Pierre‐Edouard Fournier, Jérémy Delerce, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 8, pp. 3739-3749
Open Access | Times Cited: 67
Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals
David A. Meekins, Natasha N. Gaudreault, Jüergen A. Richt
Viruses (2021) Vol. 13, Iss. 10, pp. 1993-1993
Open Access | Times Cited: 93
Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2
Elisa Saccon, Xi Chen, Flora Mikaeloff, et al.
iScience (2021) Vol. 24, Iss. 5, pp. 102420-102420
Open Access | Times Cited: 64
Surface contamination with SARS-CoV-2: A systematic review
José Gonçalves, Priscilla Gomes da Silva, Luís Paulo Reis, et al.
The Science of The Total Environment (2021) Vol. 798, pp. 149231-149231
Open Access | Times Cited: 60
Emergence in southern France of a new SARS-CoV-2 variant harbouring both N501Y and E484K substitutions in the spike protein
Philippe Colson, Jérémy Delerce, Emilie Burel, et al.
Archives of Virology (2022) Vol. 167, Iss. 4, pp. 1185-1190
Open Access | Times Cited: 42
COVID-19–associated Lung Microvascular Endotheliopathy: A “From the Bench” Perspective
Jérémie Joffre, Lauren Rodriguez, Zachary A. Matthay, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 8, pp. 961-972
Open Access | Times Cited: 42
Choosing a cellular model to study SARS-CoV-2
Gabriel Augusto Pires de Souza, Marion Le Bideau, Céline Boschi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 42
Experimental Models of COVID-19
Luis A. Caldera-Crespo, Michael J. Paidas, Sabita Roy, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 40
Antiviral Molecular Targets of Essential Oils against SARS-CoV-2: A Systematic Review
Muhammad Iqhrammullah, Diva Rayyan Rizki, Agnia Purnama, et al.
Scientia Pharmaceutica (2023) Vol. 91, Iss. 1, pp. 15-15
Open Access | Times Cited: 24
New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness
Christian Devaux, Jean‐Christophe Lagier, Didier Raoult
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 52
COVID-19-associated diarrhea
Klára Megyeri, Áron Dernovics, Zaid Isam Issa Al-Luhaibi, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 23, pp. 3208-3222
Open Access | Times Cited: 51
Isolation of Viable SARS-CoV-2 Virus from Feces of an Immunocompromised Patient Suggesting a Possible Fecal Mode of Transmission
Julie Dergham, Jérémy Delerce, Marielle Bedotto, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 12, pp. 2696-2696
Open Access | Times Cited: 46
Emergence in Southern France of a new SARS-CoV-2 variant of probably Cameroonian origin harbouring both substitutions N501Y and E484K in the spike protein
Philippe Colson, Jérémy Delerce, Emilie Burel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 41
The SARS-CoV-2 S1 Spike Protein Promotes MAPK and NF-kB Activation in Human Lung Cells and Inflammatory Cytokine Production in Human Lung and Intestinal Epithelial Cells
Christopher B. Forsyth, Lijuan Zhang, Abhinav Bhushan, et al.
Microorganisms (2022) Vol. 10, Iss. 10, pp. 1996-1996
Open Access | Times Cited: 32
SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity
Marco Rosichini, Veronica Bordoni, Domenico Alessandro Silvestris, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 4, pp. 911-921
Open Access | Times Cited: 17
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
Denisa Bojková, Philipp Reus, Leona Panosch, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 105944-105944
Open Access | Times Cited: 16
Animal Cell Lines as Expression Platforms in Viral Vaccine Production: A Post Covid-19 Perspective
S. Furkan Demirden, Ilgin Kimiz‐Gebologlu, Suphi Ş. Öncel
ACS Omega (2024)
Open Access | Times Cited: 6
Preferential apical infection of Caco-2 intestinal cell monolayers by SARS-CoV-2 is associated with damage to cellular barrier integrity: Implications for the pathophysiology of COVID-19
Clémence Garrec, Jeffrey Arrindell, Jonatane Andrieu, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0313068-e0313068
Open Access
Gut Microbiota and COVID-19: Potential Implications for Disease Severity
Giulia Rocchi, Marta Giovanetti, Francesca Benedetti, et al.
Pathogens (2022) Vol. 11, Iss. 9, pp. 1050-1050
Open Access | Times Cited: 22
Cell culture systems for isolation of SARS-CoV-2 clinical isolates and generation of recombinant virus
Da‐Yuan Chen, Jacquelyn Turcinovic, Shuchen Feng, et al.
iScience (2023) Vol. 26, Iss. 5, pp. 106634-106634
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top